Canada: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Canada

After two years of decline, the Canadian market for other medicaments for therapeutic or prophylactic uses increased by X% to $X in 2022. In general, consumption showed a prominent expansion. As a result, consumption attained the peak level and is likely to continue growth in the immediate term.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Canada

In value terms, production of other medicaments for therapeutic or prophylactic uses declined modestly to $X in 2022 estimated in export price. Over the period under review, the total production indicated a prominent increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2019 indices. The growth pace was the most rapid in 2019 with an increase of X%. As a result, production attained the peak level of $X. From 2020 to 2022, production of growth remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Canada

In 2022, exports of other medicaments for therapeutic or prophylactic uses from Canada soared to X tons, increasing by X% against 2021 figures. Over the period under review, exports enjoyed a prominent expansion. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, exports of other medicaments for therapeutic or prophylactic uses soared to $X in 2022. In general, exports posted resilient growth. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

The Netherlands (X tons), India (X tons) and the United States (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Canada, together comprising X% of total exports. South Korea, Pakistan, Brazil and Belgium lagged somewhat behind, together accounting for a further X%.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Belgium (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, the United States ($X), Belgium ($X) and the Netherlands ($X) constituted the largest markets for other medicaments for therapeutic or prophylactic uses exported from Canada worldwide, with a combined X% share of total exports.

Among the main countries of destination, Belgium, with a CAGR of X%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, rising by X% against the previous year. Overall, the export price saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2014 an increase of X% against the previous year. Over the period under review, the average export prices reached the peak figure at $X per ton in 2017; however, from 2018 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Belgium ($X per ton), while the average price for exports to the Netherlands ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Belgium (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Canada

In 2022, supplies from abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the sixth consecutive year after two years of decline. In general, imports posted a significant increase. As a result, imports attained the peak and are likely to continue growth in the immediate term.

In value terms, imports of other medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2022. Overall, imports showed significant growth. As a result, imports attained the peak and are likely to continue growth in the immediate term.

Imports by Country

In 2022, Portugal (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to Canada, with a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Portugal exceeded the figures recorded by the second-largest supplier, the United States (X tons), more than tenfold. China (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Portugal amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (X% per year) and China (X% per year).

In value terms, Portugal ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Canada, comprising X% of total imports. The second position in the ranking was taken by the United States ($X), with a X% share of total imports. It was followed by the UK, with a X% share.

From 2012 to 2022, the average annual growth rate of value from Portugal stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (X% per year) and the UK (X% per year).

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, jumping by X% against the previous year. Over the period under review, the import price continues to indicate temperate growth. The growth pace was the most rapid in 2015 an increase of X% against the previous year. Over the period under review, average import prices hit record highs at $X per ton in 2016; however, from 2017 to 2022, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Portugal ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the UK (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :